Clinical studies indicate the upsides go beyond weight management
However, its important to note: Weight management can be a valuable secondary outcome for people with T2DM, as it often improves insulin sensitivity, lowers cardiovascular risk, and enhances overall metabolic health 4 , 10
Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M (2008) The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
A total of 23 atherosclerotic New Zealand White rabbits were randomized to receive semaglutide or saline-placebo treatment
Further trials are needed to establish safe regimens and assess long-term patient outcomes
Lessai STEP UP a montr que les personnes peuvent perdre en moyenne 21 % de leur poids initial la dose la plus leve de 7,2 mg (dose autorise, mais pas encore commercialise en stylo injecteur)